---
$id: https://graph.org.ai/products/commodity/51171977
$type: Product
source: UNSPSC
code: "51171977"
title: "Pancrelipase"
class: "51171900"
classTitle: "Antiulcer and related gastrointestinal GI drugs"
family: "51170000"
familyTitle: "Drugs affecting the gastrointestinal system"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Pancrelipase

**UNSPSC Code**: 51171977
**Class**: [Antiulcer and related gastrointestinal GI drugs](Antiulcer and related gastrointestinal GI drugs.mdx)
**Family**: [Drugs affecting the gastrointestinal system](../Drugs affecting the gastrointestinal system.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an adverse event associated with metabolic and laboratory abnormalities with the molecular formula C5850H8902N1606O1739S49, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier FQ3DRG0N5K, more generally known as pancrelipase. European Medicines Agency schedules pancrelipase in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB14362MIG. The term PANCRELIPASE is an International Non-Proprietary Name or INN. As of Q4 2014, PANCRELIPASE remains the US FDA Preferred Term for this commodity.

